| Identification | Back Directory | [Name]
Nilotinib 3-Imidazolyl N-oxide | [CAS]
2139382-75-3 | [Synonyms]
Nilotinib N-Oxide Impurity 1
Nilotinib 3-Imidazolyl N-oxide
Benzamide, 4-methyl-N-[3-(4-methyl-3-oxido-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- | [Molecular Formula]
C28H22F3N7O2 | [MOL File]
2139382-75-3.mol | [Molecular Weight]
545.52 |
| Chemical Properties | Back Directory | [Melting point ]
>156°C (dec.) | [density ]
1.39±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer | [solubility ]
DMSO (Slightly), Methanol (Slightly, Heated) | [form ]
Solid | [pka]
12.86±0.70(Predicted) | [color ]
Pale Yellow |
| Hazard Information | Back Directory | [Uses]
4-Methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl]amino-N-(5-(3-oxo-4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamine is an impurity compound of Nilotinib (N465300), useful in the treatment of chronic myelogenous leukemia. It is a COVID19-related research product. |
|
| Company Name: |
TOSUN PHARM
|
| Tel: |
020-61855200 13326451905 |
| Website: |
www.toref.cn/ |
|